financetom
Business
financetom
/
Business
/
Conagra Brands Fiscal First-Quarter Results Miss Street Views as Volumes Drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Conagra Brands Fiscal First-Quarter Results Miss Street Views as Volumes Drop
Oct 2, 2024 11:06 PM

10:41 AM EDT, 10/02/2024 (MT Newswires) -- Conagra Brands' ( CAG ) fiscal first-quarter results fell year over year and missed Wall Street estimates, impacted by lower volumes and price headwinds.

The packaged food maker reported adjusted earnings of $0.53 a share for the three months through Aug. 25, down from $0.66 the year before and below the Capital IQ-polled consensus of $0.60. Sales fell 3.8% year over year to $2.79 billion, trailing the Street's view for $2.84 billion. The stock fell 7.5% in Wednesday trading.

On an organic basis, sales dropped 3.5% driven by a 1.9% negative impact from pricing amid the company's strategic investments in the quarter, and a 1.6% reduction in volume. The results in the quarter also saw an impact of roughly $27 million due to temporary manufacturing disruptions in the Hebrew National business during the key grilling season, Conagra said.

"Our team executed well to deliver on key priorities across the business during the first quarter in what continued to be a challenging environment," Chief Executive Sean Connolly said in a statement. "Our domestic retail volume progressed in-line with expectations, we increased share across the portfolio and advanced our portfolio reshaping initiatives."

In the grocery and snacks division, sales declined 1.7% to $1.18 billion amid lower prices and volume. Refrigerated and frozen revenue slipped 5.7% to $1.09 billion due to a 5.8% drop in price and mix. International sales fell 0.4% to $259.1 million while foodservice slid 7.8% to $266.7 million.

Conagra continues to project adjusted EPS between $2.60 and $2.65 for fiscal 2025, while the Street is looking for $2.61. The company reiterated its full-year organic sales guidance to be in a range of a 1.5% decline to flat versus the previous year.

"Overall, we are reaffirming our guidance for fiscal 2025, reflecting confidence in the underlying momentum of our business," according to Connolly.

For the ongoing quarter, the company anticipates topline and volume improvement on a sequential basis, Chief Financial Officer Dave Marberger said in prepared remarks.

Price: 30.05, Change: -2.67, Percent Change: -8.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Global Water Resources To Acquire Seven Water Systems From Tucson Water, Adding 2,200 Customer Connections
BRIEF-Global Water Resources To Acquire Seven Water Systems From Tucson Water, Adding 2,200 Customer Connections
May 7, 2024
May 7 (Reuters) - Global Water Resources Inc ( GWRS ): * GLOBAL WATER RESOURCES TO ACQUIRE SEVEN WATER SYSTEMS FROM TUCSON WATER, ADDING 2,200 CUSTOMER CONNECTIONS Source text for Eikon: Further company coverage: ...
Procter & Gamble Insider Sold Shares Worth $5,253,549, According to a Recent SEC Filing
Procter & Gamble Insider Sold Shares Worth $5,253,549, According to a Recent SEC Filing
May 7, 2024
09:29 AM EDT, 05/07/2024 (MT Newswires) -- Shailesh Jejurikar, Chief Operating Officer, on May 06, 2024, sold 31,859 shares in Procter & Gamble ( PG ) for $5,253,549. Following the Form 4 filing with the SEC, Jejurikar has control over a total of 50,006 shares of the company, with 9,739 shares held directly and 40,267 shares controlled indirectly. SEC Filing:...
BRIEF-IMAC Holdings Acquires Assets Of Theralink To Continue Precision Medicine Business
BRIEF-IMAC Holdings Acquires Assets Of Theralink To Continue Precision Medicine Business
May 7, 2024
May 7 (Reuters) - IMAC Holdings Inc ( BACK ): * IMAC HOLDINGS ACQUIRES ASSETS OF THERALINK TO CONTINUE PRECISION MEDICINE BUSINESS * IMAC HOLDINGS INC ( BACK ): IN PROCESS OF TRANSITIONING KEY EMPLOYEES TO STABILIZE BUSINESS OPERATIONS * IMAC HOLDINGS INC ( BACK ): ON MAY 6, BACK, IMAC MERGER SUB AND THERALINK ENTERED INTO TERMINATION AGREEMENT Source...
BRIEF-Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
BRIEF-Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
May 7, 2024
May 7 (Reuters) - Myriad Genetics Inc ( MYGN ): * MYRIAD GENETICS ANNOUNCES REORGANIZATION OF EUROPEAN OPERATIONS AND SALE OF ENDOPREDICT BUSINESS * MYRIAD GENETICS INC ( MYGN ): TO SELL ITS ENDOPREDICT BUSINESS TO EUROBIO SCIENTIFIC * MYRIAD GENETICS INC ( MYGN ): WILL LICENSE EUROBIO RIGHT TO SELL PROLARIS IN VITRO DIAGNOSTIC KITS OUTSIDE U.S. Source text...
Copyright 2023-2026 - www.financetom.com All Rights Reserved